Found: 363
Select item for more details and to access through your institution.
The impact of personal characteristics on scores on the Self‐Determination Inventory: Student report in adolescents with and without disabilities.
- Published in:
- Psychology in the Schools, 2018, v. 55, n. 9, p. 1013, doi. 10.1002/pits.22174
- By:
- Publication type:
- Article
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Relationship Between CSF Biomarkers of Alzheimer's Disease and Rates of Regional Cortical Thinning in ADNI Data.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 26, p. 77, doi. 10.3233/JAD-2011-0006
- By:
- Publication type:
- Article
Relationship Between CSF Biomarkers of Alzheimer's Disease and Rates of Regional Cortical Thinning in ADNI Data.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 26, p. 77
- By:
- Publication type:
- Article
Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34129-4
- By:
- Publication type:
- Article
Quantitative <sup>18</sup>F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients.
- Published in:
- Frontiers in Neurology, 2019, p. N.PAG, doi. 10.3389/fneur.2019.00486
- By:
- Publication type:
- Article
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 9, p. 1, doi. 10.15252/emmm.202012308
- By:
- Publication type:
- Article
GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation.
- Published in:
- EMBO Molecular Medicine, 2013, v. 5, n. 4, p. 488, doi. 10.1002/emmm.201202078
- By:
- Publication type:
- Article
Correlational analyses of biomarkers that are harmonized through a bridging study due to measurement errors.
- Published in:
- Statistical Methods in Medical Research, 2024, v. 33, n. 2, p. 185, doi. 10.1177/09622802231215810
- By:
- Publication type:
- Article
ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A cross‐sectional study of α‐synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5114, doi. 10.1002/alz.13858
- By:
- Publication type:
- Article
Medial temporal lobe gray matter microstructure in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 6, p. 4147, doi. 10.1002/alz.13832
- By:
- Publication type:
- Article
Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 6, p. 3889, doi. 10.1002/alz.13777
- By:
- Publication type:
- Article
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 1, p. 652, doi. 10.1002/alz.13449
- By:
- Publication type:
- Article
Update to the comparative analytical performance of plasma Aβ assays and their relationship to amyloid PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082763
- By:
- Publication type:
- Article
ADNI4's novel remote screening approach ‐ weighing priorities in participant selection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075152
- By:
- Publication type:
- Article
Plasma glial fibrillary acidic protein is associated with concomitant brain β‐amyloid in Lewy body disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076427
- By:
- Publication type:
- Article
Burden of cerebral small vessel disease modifies relationship between some plasma Abeta 42/40 assays, but not p‐tau181 assays, with amyloid PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079088
- By:
- Publication type:
- Article
The cerebrospinal fluid A‐T+ Alzheimer disease biomarker profile: prevalence and clinical relevance.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076814
- By:
- Publication type:
- Article
Neuropathology‐based APOE genetic risk score better quantifies Alzheimer's risk.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 8, p. 3406, doi. 10.1002/alz.12990
- By:
- Publication type:
- Article
Disentangling the heterogeneity of brain atrophy in Alzheimer's Disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.067447
- By:
- Publication type:
- Article
Appropriateness of applying CSF biomarker cutoffs from Alzheimer's disease to Parkinson's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.065161
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 5, p. 1775, doi. 10.1002/alz.12809
- By:
- Publication type:
- Article
Blood extracellular vesicles carrying synaptic function‐ and brain‐related proteins as potential biomarkers for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 3, p. 909, doi. 10.1002/alz.12723
- By:
- Publication type:
- Article
Traumatic brain injury and post‐traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 3, p. 884, doi. 10.1002/alz.12712
- By:
- Publication type:
- Article
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 3, p. 956, doi. 10.1002/alz.12697
- By:
- Publication type:
- Article
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 1, p. 307, doi. 10.1002/alz.12797
- By:
- Publication type:
- Article
Association between recollection and familiarity‐based memory measures and plasma biomarkers for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069320
- By:
- Publication type:
- Article
Plasma GFAP:NfL discriminates FTLD‐tau from FTLD‐TDP.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.064010
- By:
- Publication type:
- Article
Characterization of pre‐analytical sample handling effects on a panel of Alzheimer's disease–related blood‐based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 8, p. 1484, doi. 10.1002/alz.12510
- By:
- Publication type:
- Article
Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 7, p. 1370, doi. 10.1002/alz.12480
- By:
- Publication type:
- Article
Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 824, doi. 10.1002/alz.12422
- By:
- Publication type:
- Article
State-of-the-art of lumbar puncture and its place in the journey of patients with Alzheimer’s disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 1, p. 159, doi. 10.1002/alz.12372
- By:
- Publication type:
- Article
Comparative analytical performance of multiple plasma amyloid‐beta assays and their relationship to amyloid PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055504
- By:
- Publication type:
- Article
Stability of the novel blood‐based biomarkers under pre‐analytical sample handling conditions: Results of the SABB‐GBSC working group.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055441
- By:
- Publication type:
- Article
Racial differences in AD CSF biomarkers in persons with MCI: Implications and insights.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.052839
- By:
- Publication type:
- Article
Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 12, p. 1976, doi. 10.1002/alz.12353
- By:
- Publication type:
- Article
ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 5, p. 822, doi. 10.1002/alz.12233
- By:
- Publication type:
- Article
Identification of NPTX2 as a prognostic biomarker of Alzheimer's disease through a longitudinal CSF proteomics study in ADNI subjects: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047605
- By:
- Publication type:
- Article
A biorepository for the in‐depth validation of pre‐analytical sample handling effects on novel blood‐based biomarkers for Alzheimer's disease: The first results: Biomarkers (non‐neuroimaging): Method development and validation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045763
- By:
- Publication type:
- Article
Higher CSF STREM2/P‐tau ratio levels attenuate effects of polygenic Alzheimer's disease risk on cognitive decline and neurodegeneration: Biomarkers (non‐neuroimaging)/Prognostic utility.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044800
- By:
- Publication type:
- Article
Ultra‐performance liquid chromatography‐tandem mass spectrometry method for analysis of tau in human cerebrospinal fluid without the need of immunocapture: Biomarkers (non‐neuroimaging) / Method development and/or quality control.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040373
- By:
- Publication type:
- Article
ATN classifications in a mixed cohort of frontotemporal lobar degeneration (FTLD) and Alzheimer's disease (AD) pathology using cerebrospinal fluid neurofilament light chain (NFL): Biomarkers (non‐neuroimaging) / Differential diagnosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.039144
- By:
- Publication type:
- Article
CSF p‐Tau/AΒ<sub>40</sub> ratio adjusts for the variance of CSF production and predicts brain tau accumulation in Alzheimer's disease: Neuroimaging / multi‐modal comparisons.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038679
- By:
- Publication type:
- Article
Web‐based requisitioning, tracking and laboratory result reporting system for clinical trials using a central laboratory: Biomarkers (non‐neuroimaging)/Use in clinical trial design and evaluation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.038627
- By:
- Publication type:
- Article
Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 9, p. 1234, doi. 10.1002/alz.12110
- By:
- Publication type:
- Article